AWM
VRTX icon

Activest Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Activest Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Buy
58
+12
+26% +$5.32K 0.01% 363
2026
Q1 		$20.6K Buy
46
+40
+667% +$18.7K ﹤0.01% 518
2025
Q4 		$2.93K Sell
6
-10
-63% -$4.31K ﹤0.01% 841
2025
Q3 		$6.13K Sell
16
-106
-87% -$44.3K ﹤0.01% 601
2025
Q2 		$54.1K Buy
122
+71
+139% +$32.7K 0.01% 200
2025
Q1 		$24.7K Buy
+51
New +$23.8K 0.01% 266
2023
Q3 		– Sell
-116
Closed -$40.6K – 401
2023
Q2 		$39.8K Buy
+116
New +$39.1K 0.03% 101

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Activest Wealth Management's VRTX Position: Q2 2026 in Review

Activest Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q2 2026, buying an estimated $5.32K and bringing the position to 58 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #363.

Activest Wealth Management first reported a position in VRTX in Q2 2023 and has held it in 7 quarters since. The position peaked at $54.1K in Q2 2025. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Activest Wealth Management held 58 shares of Vertex Pharmaceuticals worth $28.8K as of Q2 2026.
  • Activest Wealth Management bought 12 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.32K.
  • Vertex Pharmaceuticals made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #363 holding.
  • Activest Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • Activest Wealth Management's Vertex Pharmaceuticals position peaked at $54.1K in Q2 2025.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.